...
首页> 外文期刊>Medicine. >Chronic cystoisosporiasis in an immunocompetent adult
【24h】

Chronic cystoisosporiasis in an immunocompetent adult

机译:在免疫活性的成人中的慢性膀胱孢子病

获取原文

摘要

RATIONALE:Cystoisosporiasis is an intestinal infectious disease caused by a coccidian protozoa, Cystoisospora belli (C. belli). It can cause prolonged and refractory diarrhea most commonly in immunocompromised patients, while immunocompetent individuals usually exhibit no symptoms or self-limited diarrhea.PATIENT CONCERNS:We herein report a case of chronic cystoisosporiasis in an immunocompetent patient. A 62-year-old man, who had been first diagnosed with cystoisosporiasis 15?years ago and had been treated with oral administration of trimethoprim-sulfamethoxazole (TMP-SMX), complained of persistent watery diarrhea. He was negative for anti-human immunodeficiency virus antibody and anti-human T-cell leukemia virus type 1 (HTLV-1) antibody.DIAGNOSIS:Biopsy specimens from the duodenum revealed oocysts in the atrophic absorptive epithelium and protozoa were detected through stool examination, indicating the recurrence of cystoisosporiasis. Capsule endoscopy showed diffuse atrophic mucosa with white villi in the entire small intestine. We diagnosed him with chronic cystoisosporiasis that occurred in an immunocompetent adult.INTERVENTIONS:Since oral administration of TMP-SMX and ciprofloxacin were ineffective, the intravenous administration of TMP-SMX was initiated.OUTCOMES:Intravenous TMP-SMX exhibited a significant improvement.LESSONS:This case indicates that even immunocompetent individuals may develop recurrent and refractory cystoisosporiasis. Furthermore, intravenous treatment of antibiotic agents should be considered when the impaired absorptive ability from the small intestine is suspected.Copyright ? 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
机译:理由:膀胱梭病毒是一种由Coccidian原生动物,Cystoisospora Belli(C. Belli)引起的肠道传染病。它可能导致免疫组织患者中最常常见的令人长长的令人难以忍受的腹泻,而免疫功能性的个体通常没有表现出症状或自动有限的腹泻。本文报告了免疫活性患者中的慢性膀胱孢子病病例。一名62岁的男子曾首次被诊断出患有半血管孢子病15?多年前,并已用口服施用Trimethokim-磺胺甲氧唑(TMP-SMX)治疗,抱怨持久的水腹泻。他对抗人免疫缺陷病毒抗体和抗人类T细胞白血病病毒型1(HTLV-1)抗体。诊断:来自十二指肠的活检标本显示通过粪便检查检测到萎缩吸收上皮和原生动物中的卵囊,表明膀胱孢子病复发。胶囊内窥镜检查显示弥漫性萎缩粘膜,在整个小肠中有白色绒毛。我们用慢性膀胱孢子体诊断出在免疫活性成人中发生的慢性膀胱孢子病。由于TMP-SMX和环丙沙星的口服给药无效,因此启动了TMP-SMX的静脉内施用。静脉注射TMP-SMX显示出显着的改进:这种情况表明均匀的免疫功能性均可能产生复发性和难治性膀胱孢子病。此外,当疑似小肠受损的吸收能力时,应考虑对抗生素剂的静脉治疗。柔晕? 2021提交人。由Wolters Kluwer Health,Inc。出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号